Early vs. late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction
Article Abstract:
Primary percutaneous coronary intervention (PCI) has always been the reperfusion strategy in ST-segment elevation myocardial infarction (STEMI) and meta-analysis of trials of early vs. late intravenous administration of Gp IIb/IIIa inhibitors in STEMI was done. In 6 meta-analysis early administration of inhibitors in STEMI helped improve coronary patency with positive trends for clinical outcomes, but further evaluations are suggested.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction
Article Abstract:
The study conducted determines whether protection of the distal microcirculation from throm-boembolic debris liberated during primary percutaneous coronary intervention (PCI) results in improved reperfusion and decreased infract size. The result reveals that a distal balloon occlusion and aspiration system effectively retrieves embolic debris in most patients with acute segment elevation myocardial infarction undergoing emergent PCI.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction
Article Abstract:
A study was conducted to assess the value of stem cell mobilization by Granulocyte Colony Stimulating Factor (G-CSF) therapy in patients with acute Myocardial Infarction (MI). The results showed that stem cell mobilization by G-CSF therapy in patients with acute MI and successful mechanical reperfusion has no influence on infarct size, left ventricular function, or coronary restenosis.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction
- Abstracts: Management of patients undergoing percutaneous coronary revascularization. Management of patients undergoing percutaneous coronary interventions
- Abstracts: Expression and regulation of luteinizing hormone/human chorionic gonadotropin receptors in ovarian cancer and its correlation to human chorionic gonadotropin-doxorubicin sensitivity
- Abstracts: Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: Correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival
- Abstracts: Oral antiplatelet therapy in cerebrovascular disease, Coronary artery disease, and peripheral arterial disease